You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 248 No. 8, August 27, 1982 TABLE OF CONTENTS
  JAMA
  •  Online Features
  LETTERS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Duchenne's Muscular Dystrophy-Reply

Fred A. Ziter, MD
University of Utah College of Medicine Salt Lake City

JAMA. 1982;248(8):923.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.—

Dr Renshaw has summarized briefly the value of supportive therapy in school-aged boys with DMD. We endorse his comments completely, and some of our previous publications have recognized the value of such a multidisciplinary approach.1,2 Despite the merits of such palliative programs, they do not seem to have much relevance to the issue of early diagnosis of DMD, which our article addressed. As long as there remains no therapy that will reverse or arrest the muscle degeneration in these youngsters, many physicians will question the merits of early diagnosis. . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.